Cargando…

An observational report of universal GeneXpert testing of inpatients with diagnosed or presumptive TB in the Philippines

BACKGROUND: The Philippines is a high TB and multidrug-resistant TB burden country. Although the scale-up of GeneXpert testing is occurring, the benefits of universal Xpert-Mycobacterium tuberculosis/ rifampicin (MTB/RIF) testing in inpatients have not been documented. METHODS: Routine GeneXpert tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thi, Aye Myat, Lee, Nathaniel, Parris, Victoria, Marin, Flora P, Roy, Lynsil, Calapis, Rugaiya W, Ariyoshi, Koya, Parry, Christopher M, Cox, Sharon E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456596/ https://www.ncbi.nlm.nih.gov/pubmed/32592398 http://dx.doi.org/10.1093/trstmh/traa044

Ejemplares similares

Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study
por: Lee, Nathaniel, et al.
Publicado: (2019)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Patterns and predictors of co-morbidities in Tuberculosis: A cross-sectional study in the Philippines
por: White, Laura V., et al.
Publicado: (2020)

Prospective evaluation of GeneXpert for the diagnosis of HIV- negative pediatric TB cases
por: Giang, Do Chau, et al.
Publicado: (2015)

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal
por: Sah, Shiv Kumar, et al.
Publicado: (2020)

Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review
por: Brown, Scott, et al.
Publicado: (2021)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018)

P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive
por: Setianingrum, Findra, et al.
Publicado: (2022)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Comparative Performance of Line Probe Assay and GeneXpert in the Detection of Rifampicin Monoresistance in a TB-Endemic African Country
por: Mchaki, Betty R., et al.
Publicado: (2022)

Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years
por: Getahun, Desalegn Addise, et al.
Publicado: (2023)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
por: Decroo, Tom, et al.
Publicado: (2017)

Comparison of LAMP, GeneXpert, Mycobacterial Culture, Smear Microscopy, TSPOT.TB, TBAg/PHA Ratio for Diagnosis of Pulmonary Tuberculosis
por: Deng, Yan, et al.
Publicado: (2021)

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
por: Gebretsadik, Daniel, et al.
Publicado: (2020)

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections
por: Florea, Dragoş, et al.
Publicado: (2014)

Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020)

Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation
por: Raizada, Neeraj, et al.
Publicado: (2018)

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
por: Hermans, Sabine M., et al.
Publicado: (2017)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital
por: Shrestha, Poojan, et al.
Publicado: (2015)

Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2019)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v4taeuj2se38073rurr6pgladk